Seeing Is Believing
MDGL is currently covered by 10 analysts with an average price target of $383.86. This is a potential upside of $69.69 (22.18%) from yesterday's end of day stock price of $314.17.
Madrigal Pharmaceuticals's activity chart (see below) currently has 113 price targets and 107 ratings on display. The stock rating distribution of MDGL is 81.58% BUY, 15.79% HOLD and 2.63% SELL.
Analysts average stock forecasts to be materialized ratio is 85.24% with an average time for these price targets to be met of 360.33 days.
Highest price target for MDGL is $390, Lowest price target is $236, average price target is $383.86.
Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 05-Nov-2024. First documented stock forecast 29-Oct-2014.
Currently out of the existing stock ratings of MDGL, 31 are a BUY (81.58%), 6 are a HOLD (15.79%), 1 are a SELL (2.63%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$236
$-52.58 (-18.22%)
$200
16 days ago
(05-Nov-2024)
10/13 (76.92%)
$-94.07 (-28.50%)
261
Buy
$350
$61.42 (21.28%)
$320
29 days ago
(23-Oct-2024)
10/11 (90.91%)
$147.52 (72.86%)
357
Buy
$390
$101.42 (35.14%)
$390
30 days ago
(22-Oct-2024)
14/16 (87.5%)
$186.41 (91.56%)
286
Buy
$360
$71.42 (24.75%)
$325
3 months 13 days ago
(08-Aug-2024)
5/6 (83.33%)
$116.36 (47.76%)
308
Buy
$385
$96.42 (33.41%)
$381
4 months 5 days ago
(16-Jul-2024)
4/10 (40%)
$111.28 (40.65%)
219
What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on MDGL (Madrigal Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?
Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?
Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?